Glenmark Pharmaceuticals Ltd. Financials

15:59 Jun 13

Glenmark Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1669.90
+30.30 (+1.85%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Glenmark Pharmaceuticals Ltd. Financials

Glenmark Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1669.90
+30.30 (+1.85%)
15:59 Jun 13
Quality
image/svg+xml

68/100
High Financial Strength

Valuation
image/svg+xml

38/100
Mid Valuation

Technical

52/100
Technically Neutral

Strength

7

Weakness

6

Opportunity

1

Threats

0

11.83 %

ROE %

6.52 %

ROA %

37.10

EPS

313.60

BVPS

7.86 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
10943.93 12304.9 12990.11 11813.1 13321.74
Operating Expenses +
8859.56 9984.6 10711.74 10617.76 10970.36
Raw Material
3888.07 4396.42 4862.05 4608.99 4567.27
Increase Decrease in Cost
-189.25 -11.14 -325.09 -195.62 -213.93
Other Manufacturing Expense
44.99 74.42 0 0 0
Employee Cost
2343.71 2447.42 2780.96 2868.14 3022.06
Miscellaneous Expenses
4272.58 5312.8 5930.34 6238.59 6726.96
Operating Profit
2084.37 2320.3 2278.37 1195.34 2351.38
Other Income
50.22 166.67 316.79 839.99 113.72
Depreciation
443.55 486.72 611.27 581.91 486.01
Interest
353.11 298.1 349.58 515.97 207.06
Profit before tax and exceptio..
1337.93 1702.16 1634.3 937.45 1772.03
Exceptional Items
44.54 -260.91 -765.85 -900.96 -372.82
PBT
1382.48 1441.25 868.45 36.5 1399.21
Provision for Taxation
412.39 447.6 491.05 1867.34 352.07
Net Profit
970.09 993.65 377.4 -1433.52 1047.14
NET Profit after MI
970.04 941.71 297.24 -1501.67 1047.1
EPS
34.38 33.37 10.53 -53.22 37.11
Operating Profit Margin (%)
19.05 18.86 17.54 10.12 17.65
Net Profit Margin (%)
8.86 7.65 2.29 -12.71 7.86

Glenmark Pharmaceuticals Ltd. Shareholding

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 46.60 46.60 46.60 46.60 46.60
FII 23.20 23.50 23.00 21.00 21.40
MF 12.90 12.10 11.40 10.90 10.60
Others 1.70 1.80 1.90 3.10 2.80
Shareholder Shares Holding %
Download Our App On: